Positive context积极背景
Stocks股票 / Health Care / UTHR
United Therapeutics · Health Care
UTHR US listed · USD美股 · 美元
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing.United Therapeutics Corporation 是一家美国生物技术公司，致力于开发与器官移植（包括异种移植）相关的药物和技术。该公司的许多产品专注于肺部疾病和器官制造。
Large cap大盘 · $21B
Health Care
S&P 400标普400中盘
Secular growth长期成长
$475.45
+$3.24 · +0.69%
52w low52周低 $410high高 $605
Hold off — timing against you暂缓 — 时机不利
Downtrend — stand aside until a new cycle low forms and confirms.下跌趋势——观望，直至新的周期低点形成并确认。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
34
Depressed偏低
vs 50-day average相对50日均线
-7.1% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
-9.3% below下方
Long trend down长期向下
Volatility波动率
53th percentile第53百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0437
Estimates being cut预期下调
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 2.6%
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | UTHR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 15.55x | 29.58 | |
| P/B市净率 | 2.92x | 3.30 | |
| P/S市销率 | 6.52x | 3.19 | |
| Earnings yield盈利收益率 | 6.43% | 2.56 | |
| FCF yield自由现金流收益率 | 5.02% | 4.11 | |
| Shareholder yield股东收益率 | 4.82% | 1.87 | |
| EV/EBITDA企业价值/EBITDA | 12.16x | 18.26 | |
| P/FCF市值/自由现金流 | 19.94x | 21.34 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$3.2B2025
20202025
5-yr growth5年复合增速 16.5%
Earnings per share每股收益
$27.862025
20202025
5-yr growth5年复合增速 19.3%
Free cash flow自由现金流
$1.0B2025
20202025
Gross margin毛利率
87.9%
Operating margin营业利润率
46.9%
Net margin净利率
41.9%
FCF margin自由现金流利润率
49.1%
Balance-sheet quality财务体质 7/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 19%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.99
Current ratio流动比率6.60
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$1.0B
Stock-based comp股权薪酬$147.7M
Share count change (1y)股数变化（1年）-2.7%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +36.0%空头仓位变动 +36.0%
Technical技术面
UTHR daily MACD crossed downUTHR 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$731.9M net (1 buyers, 11 sellers)-$731.9M 净值（1 买家，11 卖家）
Signal history信号历史
engine events引擎事件
NEARING A LOW → DOWNTREND接近低点 → 下跌趋势
AVOID. Failed cycle — price broke below the low that started this cycle, which historically means the larger trend is rolling over (~80% of cases). Last cycle was left-translated (topped early) — a bearish structural tell回避。失败周期——价格跌破了启动本周期的低点，历史上这通常意味着更大的趋势正在掉头向下（约 80% 的情形）。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Sep 23, 2026
UTHR daily MACD crossed downUTHR 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $489.42.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$489.42。
Sep 22, 2026
UTHR daily MACD crossed upUTHR 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $497.59.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$497.59。
Sep 21, 2026
DOWNTREND → NEARING A LOW下跌趋势 → 接近低点
GET READY准备
Sep 21, 2026
UTHR daily MACD crossed downUTHR 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $493.10.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$493.10。
Sep 17, 2026
UNCONFIRMED TURN → DOWNTREND未确认转向 → 下跌趋势
AVOID回避
Sep 17, 2026
UTHR broke down vs the marketUTHR 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $497.27.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$497.27。
Sep 14, 2026
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 14, 2026
UTHR daily MACD crossed upUTHR 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $502.70.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$502.70。
Sep 11, 2026
UNCONFIRMED TURN → DOWNTREND未确认转向 → 下跌趋势
AVOID回避
Sep 11, 2026
UTHR broke down vs the marketUTHR 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $497.11.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$497.11。
Sep 10, 2026
Death cross on UTHRUTHR 死叉
The 50-day average crossed below the 200-day — a slow, widely-watched bearish trend signal. $503.86.50日均线下穿200日均线 — 一个滞后但广受关注的看空趋势信号。$503.86。
Showing the last 15 of显示最近15条，共 273 signals条信号
Company profile公司档案
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing.United Therapeutics Corporation 是一家美国生物技术公司，致力于开发与器官移植（包括异种移植）相关的药物和技术。该公司的许多产品专注于肺部疾病和器官制造。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
- Receivables stretch
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 15.6× | 29.6× | 83% |
| Price / Book市净率 | 2.9× | 3.3× | 58% |
| Price / Sales市销率 | 6.5× | 3.2× | 24% |
| EV / EBITDAEV/EBITDA | 12.2× | 18.3× | 78% |
| Earnings yield盈利收益率 | 6.4% | 2.6% | 88% |
| Free-cash-flow yield自由现金流收益率 | 7.5% | 5.5% | 78% |
| Shareholder yield股东综合回报率 | 4.8% | 1.9% | 82% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
86/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
27/100 — weaker than most弱于多数
vs market, 6 months相对大盘（6个月）
20/100 — weaker than most弱于多数
vs market, 12 months相对大盘（12个月）
50/100 — middle of the pack居中
Rank in sector行业内排名
#31 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -3.9% | +1.3% |
| 1 Month近1月 | -8.0% | +0.9% |
| 3 Months近3月 | -12.4% | +6.1% |
| 6 Months近6月 | -9.1% | +22.3% |
| Year to date年初至今 | -4.3% | +13.8% |
| 1 Year近1年 | +11.8% | +18.5% |
| 3 Years近3年 | +106.8% | +87.8% |
Trading information交易信息
Beta vs market贝塔
0.27
Volatility rank波动率分位
53th pctile
Short interest空头占比
6.4% of float
Market cap市值
$21B
EPS (trailing)每股收益
$30.58
Off 52-week high距52周高点
-20.3%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $1.5B | $1.7B | $1.9B | $2.3B | $2.9B | $3.2B |
| EPS每股收益 | $11.54 | $10.06 | $15.00 | $19.81 | $24.64 | $27.86 |
| Free cash flow自由现金流 | $696M | $477M | $664M | $748M | $1.1B | $1.0B |
| Gross margin毛利率 | 92.7% | 92.7% | 92.2% | 88.9% | 89.2% | 87.9% |
| Net margin净利率 | — | — | — | 42.3% | 41.5% | 41.9% |
| FCF margin自由现金流利润率 | 46.9% | 28.3% | 34.3% | 32.1% | 37.6% | 32.7% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$3.2B
Gross profit毛利润
$2.8B
Net income净利润
$1.3B
Operating cash flow经营现金流
$1.6B
Total assets总资产
$7.9B
Shareholder equity股东权益
$7.1B
Buybacks股票回购
$1.0B
Shares outstanding总股本
0.04B
Returns & growth回报与增长
Return on equity股本回报率
18.8%
Return on assets资产回报率
16.9%
Profit growth利润增速
+11.7%
Asset growth资产增速
+7.0%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Pricing power: gross margin −4.8pts over 6 years定价能力：毛利率 6 年下降 4.8 个百分点
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: Altman Z 18.91 — safe zone资产负债表：Altman Z 18.91——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
34
RSI (2-day)RSI（2日）
26
vs 20-day average相对20日均线
-4.3%
vs 50-day average相对50日均线
-7.1%
vs 200-day average相对200日均线
-9.3%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down — fresh downturn动能向下——刚刚转弱
3-day3日线
momentum down动能向下
Weekly周线
momentum down动能向下
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
44/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $7.27 | $6.82 | +6.6% |
| Mar 2026 | $5.82 | $6.73 | -13.5% |
| Dec 2025 | $7.70 | $6.78 | +13.6% |
| Sep 2025 | $7.16 | $6.89 | +3.9% |
Estimate revisions预期修正
Analysts covering覆盖分析师
13
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-9.6%
Net upgrades, 30 days净上调（30天）
-9
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$731.9M
Insider buyers vs sellers内部人买家vs卖家
1 : 11
Short interest空头占流通盘
6.4%
Days to cover回补天数
3.9
Short interest change空头变化
+36.0%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
ROBO Global Healthcare Technology & InnovationROBO Global Healthcare Technology & Innovation
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Feb · 67%
Weakest month最弱月份
Jan · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 0% | -2.2% | 3 |
| Feb2月 | 67% | +5.1% | 3 |
| Mar3月 | 67% | +2.2% | 3 |
| Apr4月 | 33% | -1.1% | 3 |
| May5月 | 67% | +5.4% | 3 |
| Jun6月 | 33% | -2.6% | 3 |
| Jul7月 | 0% | -4.1% | 3 |
| Aug8月 | 50% | +10.8% | 4 |
| Sep9月 | 50% | +0.8% | 4 |
| Oct10月 | 67% | +4.6% | 3 |
| Nov11月 | 67% | +7.6% | 3 |
| Dec12月 | 33% | -4.6% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。